Royal Philips Electronics announced that it will lead a new European Union (EU) funded research project called euHeart, which is aimed at improving the diagnosis, therapy planning and treatment of cardiovascular disease – one of the biggest causes of mortality in the western world.
An implantable device that monitors fluid build up in the lungs of heart failure patients and alerts doctors when intervention is needed can significantly reduce hospitalisations, according to a study published in The Lancet.
IntraPace has received European CE mark approval for its abiliti system as a treatment for obesity.
